Načítá se...
Engineering Escherichia coli for Soluble Expression and Single Step Purification of Active Human Lysozyme
Genetically engineered variants of human lysozyme represent promising leads in the battle against drug-resistant bacterial pathogens, but early stage development and testing of novel lysozyme variants is constrained by the lack of a robust, scalable and facile expression system. While wild type huma...
Uloženo v:
Hlavní autoři: | , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
2012
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3594478/ https://ncbi.nlm.nih.gov/pubmed/23220215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbiotec.2012.11.007 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|